摘要
属于吡哆醛5''-磷酸依赖性酶的II族的芳香族氨基酸,半胱氨酸亚磺酸,谷氨酸和组氨酸脱羧酶分别催化多巴胺/ 5-羟色胺,亚牛磺酸,γ-氨基丁酸和组胺的合成。考虑到这些反应产物都是必需的生物活性分子,从进化,生物化学和药理学的角度对II组脱羧酶进行了长时间的研究。尽管事实上它们都属于共同的折叠型,在进化过程中每个脱羧酶已经发展了负责其底物特异性的独特结构元件。结合文献更新与生物信息学分析,这次审查集中在这些酶共享的一些结构决定因素揭示其内在底物特异性和突出一些残留/地区的催化能力的重要性。特别地,出现两个关键的结构特征:1)移动催化环,和2)伴随apo-holo跃迁的开 - 关闭构象。提请注意这些元素在将微妙的结构修饰与功能特性相关联以在病理状况的分子水平上理解是至关重要的。这由这些脱羧酶在几种不同的病理状态(自身免疫性疾病,I型糖尿病,帕金森病,芳香族氨基酸脱羧酶缺乏症,图雷特综合征和胆管癌)中起越来越重要的作用了得到证实。
关键词:
Current Medicinal Chemistry
Title:New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5’-Phosphate Decarboxylases
Volume: 24 Issue: 3
关键词:
摘要: Aromatic amino acid, cysteine sulfinic acid, glutamate and histidine decarboxylases, belonging to group II of pyridoxal 5'-phosphate-dependent enzymes, catalyze the synthesis of dopamine/serotonin, hypotaurine, γ-aminobutyric acid and histamine, respectively. Considering that these reaction products are all essential bioactive molecules, group II decarboxylases have been long studied from an evolutionary, biochemical and pharmacological standpoint. Despite the fact that they all belong to a common fold-type, during evolution each decarboxylase has evolved unique structural elements responsible for its substrate specificity. Combining a literature update with bioinformatic analyses, this review focuses on some structural determinants shared by these enzymes revealing their intrinsic substrate specificity and highlighting the importance of some residues/regions for catalytic competence. In particular, two key structural features emerge: 1) a mobile catalytic loop, and 2) an open-to-close conformation accompanying the apo-holo transition. Drawing attention on these elements is crucial in correlating subtle structural modifications to functional properties for the understanding, at a molecular level of a pathological condition. This is corroborated by the increasingly important role played by these decarboxylases in several different pathological states (autoimmune diseases, type I diabetes, Parkinson's disease, aromatic amino acid decarboxylase deficiency, Tourette's syndrome and cholangiocarcinoma).
Export Options
About this article
Cite this article as:
New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5’-Phosphate Decarboxylases, Current Medicinal Chemistry 2017; 24 (3) . https://dx.doi.org/10.2174/0929867324666161123093339
DOI https://dx.doi.org/10.2174/0929867324666161123093339 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism Oxidative Stress in the Molecular Mechanism of Pathogenesis at Different Diseased States of Organism in Clinics and Experiment
Current Drug Targets - Inflammation & Allergy Topiramate: Its Pharmacological Properties and Therapeutic Efficacy in Epilepsy
Mini-Reviews in Medicinal Chemistry 1,2,4-Triazine Analogs as Novel Class of Therapeutic Agents
Mini-Reviews in Medicinal Chemistry Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications
Current Neuropharmacology Obstructive Sleep Apnea Syndrome: From Phenotype to Genetic Basis
Current Genomics Epigenetic Modification in Neuropathic Pain
Current Pharmaceutical Design Transglutaminases - Possible Drug Targets in Human Diseases
Current Drug Targets - CNS & Neurological Disorders Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Disorders of Protein Biogenesis and Stability
Protein & Peptide Letters Cell-based Treatment of Cerebral Palsy: Still a Long Way Ahead
Current Stem Cell Research & Therapy Sestrins: A New Kid for Stroke Treatment?
Current Drug Delivery Establishing Genomic/Transcriptomic Links Between Alzheimer’s Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach
CNS & Neurological Disorders - Drug Targets Xenosensors CAR and PXR at Work: Impact on Statin Metabolism
Current Drug Metabolism Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Recent Developments in the Treatment of Alcoholic Chronic Pancreatitis
Current Drug Abuse Reviews Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo
CNS & Neurological Disorders - Drug Targets Recent Advances in Neuromyelitis Optica Spectrum Disorder: Pathogenesis, Mechanisms and Potential Treatments
Current Pharmaceutical Design Histamine H3 Receptor Ligands in the Group of (Homo)piperazine Derivatives
Current Medicinal Chemistry Computational Study and Synthesis of a New Class of Anticonvulsants with 6 Hz Psychomotor Seizure Test Activity: 2-(1,3-benzodioxol-5-yloxy)- N'-[substituted]-acetohydrazides
Medicinal Chemistry